Loading resource…

JAMA
Transcatheter aortic valve implant (TAVI) is increasingly performed in younger and healthier patients with severe aortic valve stenosis. Antithrombotic therapy after TAVI is crucial for optimizing valve durability and clinical outcomes. This randomized clinical trial investigates the outcomes of two different antithrombotic strategies in patients undergoing TAVI, focusing on their safety and efficacy.
No account needed